HomeCBIO • NASDAQ
add
Crescent Biopharma Inc
Previous close
$13.41
Year range
$9.81 - $37.00
Market cap
186.30M USD
Avg Volume
57.26K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 25.88M | — |
Net income | -24.61M | — |
Net profit margin | — | — |
Earnings per share | -1.37 | — |
EBITDA | -25.86M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 133.26M | — |
Total assets | 138.27M | — |
Total liabilities | 21.63M | — |
Total equity | 116.64M | — |
Shares outstanding | 19.55M | — |
Price to book | 2.33 | — |
Return on assets | -43.77% | — |
Return on capital | -49.92% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -24.61M | — |
Cash from operations | -17.54M | — |
Cash from investing | -586.00K | — |
Cash from financing | -1.25M | — |
Net change in cash | -19.38M | — |
Free cash flow | -11.12M | — |
About
Founded
2024
Headquarters
Website
Employees
41
